tirzepatide + b12 injection Programs Tirzepatide, Glycine + Vitamin B12

Emerging evidence suggests the potential benefits of GLP-1 RAs in the treatment of IBD through enhanced mucosal healing and reduced inflammation

While semaglutide is not specifically approved for treating colitis, some studies suggest that it could help manage inflammation, which is a big part of colitis symptoms

Tirzepatide functions as a dual GLP-1 and GIP receptor agonist, directly addressing the hormonal and metabolic dysregulation that accelerates weight gain during this life stage

Every other compounded GLP-1 provider I have ever seen or researched has a threshold set that looks something like this: To qualify for GLP-1s, you must have : 1.) BMI 30 (This qualifies as obese) OR 2.) BMI 27 plus at least one weight-related condition, such as: Type 2 diabetes High blood pressure High cholesterol Sleep apnea Insulin resistance or PCOS (depending on provider) Willow has put forth no such guidelines

Required Testing to Ensure Safety Sterile compounded medications must undergo multiple tests to ensure safety and quality, including: Sterility testing: Confirms no microbial growth is present Endotoxin testing: Detects harmful bacterial fragments that could cause illness if injected Potency testing: Verifies the medication contains the correct strength as labeled In addition to required testing, some pharmacies implement further quality measures